Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
Hijos-Mallada G, Alfaro E, Navarro M, Cañamares P, Ariño I, Charro M, Bruno C, Solano M, Pardillos A, Jimeno C, Carrera-Lasfuentes P, Lanas A, Domper-Arnal MJ. Hijos-Mallada G, et al. Among authors: navarro m. Gastroenterol Hepatol. 2023 Nov;46(9):702-709. doi: 10.1016/j.gastrohep.2023.01.007. Epub 2023 Jan 27. Gastroenterol Hepatol. 2023. PMID: 36716926 Free PMC article.
NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs.
García-Rayado G, Navarro M, Lanas A. García-Rayado G, et al. Among authors: navarro m. Expert Rev Clin Pharmacol. 2018 Oct;11(10):1031-1043. doi: 10.1080/17512433.2018.1516143. Epub 2018 Sep 20. Expert Rev Clin Pharmacol. 2018. PMID: 30139288 Review.
Black oesophagus (acute oesophageal necrosis).
Laredo V, Navarro M, Alfaro E, Cañamares P, Abad D, Hijos G, García S, Velamazán R, Blas JM, Ferrández Á. Laredo V, et al. Among authors: navarro m. Gastroenterol Hepatol. 2020 Apr;43(4):201-202. doi: 10.1016/j.gastrohep.2019.10.005. Epub 2019 Dec 4. Gastroenterol Hepatol. 2020. PMID: 31810795 English, Spanish. No abstract available.
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology.
Lué A, Hijos G, Sostres C, Perales A, Navarro M, Barra MV, Mascialino B, Andalucia C, Puente JJ, Lanas Á, Gomollon F. Lué A, et al. Among authors: navarro m. Therap Adv Gastroenterol. 2020 May 18;13:1756284820920786. doi: 10.1177/1756284820920786. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32523623 Free PMC article.
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort.
Hijos-Mallada G, Lué A, Velamazan R, Saura N, Abril C, Lorenzo M, Navarro M, Chueca E, Arechavaleta S, Gomollón F, Lanas Á, Sostres C. Hijos-Mallada G, et al. Among authors: navarro m. Front Med (Lausanne). 2021 Jun 4;8:665786. doi: 10.3389/fmed.2021.665786. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34150803 Free PMC article.
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer.
Hijos-Mallada G, Saura N, Lué A, Velamazan R, Nieto R, Navarro M, Arechavaleta S, Chueca E, Gomollon F, Lanas A, Sostres C. Hijos-Mallada G, et al. Among authors: navarro m. Cancers (Basel). 2023 Jan 24;15(3):721. doi: 10.3390/cancers15030721. Cancers (Basel). 2023. PMID: 36765678 Free PMC article.
2,591 results